HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
NCT00188357 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360
Last updated 2007-02-14
Summary
Several studies have shown that persons with systemic lupus erythematosus (SLE) have poor general health and a higher risk of heart attack and bone loss (osteoporosis) compared to the general population. Some of the risks associated with heart attacks and bone loss are modifiable (can be changed). For example, high blood pressure, high cholesterol, smoking, lack of exercise are risk factors associated with heart attacks that can be changed. Whereas, age and a family history of heart attacks are risk factors that can not be changed. Similarly, a diet low in calcium, smoking and lack of exercise are modifiable risk factors associated with osteoporosis; while, family history and age are not modifiable. The Health Improvement and Prevention Program (HIPP) in Systemic Lupus Erythematosus was developed to increase the general health in persons who have lupus and to help reduce the risk of heart attacks and bone loss. This intervention program gives comprehensive
information about lupus and provides tools on how to live better with lupus. The program includes visits with a nurse case manager who will work in close collaboration with the lupus team. She will work on an individual basis with each participant to develop a mutually agreed upon personalized care plan aimed at improving general health, coping skills and heart and bone health.
HIPP STUDY (Health Improvement And Prevention Program)
Dr Paul Fortin Principal Investigator
Primary and Secondary objectives:
* To improve health status, decrease cardiovascular risk and improve endothelial function in persons with SLE compared to usual care.
* To improve bone health behaviors and prevent decrease in bone mineral density.
* To improve adherence to treatments.
* To help persons with Lupus move toward wellness by increasing knowledge.
* To show that HIPP is cost effective and could become standard care.
Duration: 2 years
Enrollment 240 patients
Study Design:
* Randomized prospective study of HIPP compared to usual care, patients will be crossed over at Mth 12. Data collected for 24 mths.
* Demographic, health status, cost, SLE knowledge, coping, cardiovascular and osteoporosis information will be collected.
* All patients will undergo clinical evaluation to measure disease activity, BMD (every 2 years) and Flow mediated Doppler (every year)
* HIPP now patients will attend 4 knowledge sessions, covering SLE, coping with chronic disease, cardiovascular disease in Lupus, bone health in Lupus.
* HIPP now patients will be followed by nurse coordinator and receive an individualized risk assessment, telephone follow-up, smoking cessation counseling. For those found at risk stress reduction (Mindfulness Based Stress Reduction) and or bone health program will be provided. Hipp now patients will attend Cardiac Rehabilitation Program at TWH. All HIPP now pts will attend the Cardiac Rehabilitation program at the TWH.
Inclusion Criteria:
SLE according to ACR, \>18 yr, Female, must read and write french or english
Exclusion Criteria:
MI, TIA, CVA, Other arterial occlusion, PVD, Osteoporosis as defined by BMD, Pregnant now, active cancer
For further information contact Study Coordinator Anne Cymet Tel # 13-2895 Pager 416-664-
Conditions
Interventions
- BEHAVIORAL
-
Education
Sponsors & Collaborators
-
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
The Arthritis Society, Canada
collaborator OTHER -
University Health Network, Toronto
lead OTHER
Principal Investigators
-
Paul R Fortin, MD,FRCP,MPH · University Health Network, Toronto
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Wellness & Workforce Solution for Lupus/Lupus Nephritis
NCT06217107 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fatigue in Lupus Intervention Programmes (FLIP)
NCT06308770 ·Status: RECRUITING ·Phase: NA
-
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
NCT00054938 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Quality of Life for African American Female Adolescents With Lupus
NCT00068874 ·Status: COMPLETED ·Phase: PHASE2
-
Activity and Nutrition Trial in Lupus to Energize and Renew
NCT02281513 ·Status: COMPLETED ·Phase: NA
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT00985803 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
NCT06166199 ·Status: RECRUITING ·Phase: NA
-
Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus
NCT03218033 ·Status: COMPLETED ·Phase: NA
-
Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE
NCT06720584 ·Status: COMPLETED ·Phase: NA
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
Lupus Cohort--Thrombotic Events and Coronary Artery Disease
NCT00005436 ·Status: COMPLETED
-
Insulin Resistance and Atherosclerosis in Women With Lupus
NCT00544102 ·Status: COMPLETED
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
NCT05818254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients
NCT04032496 ·Status: UNKNOWN ·Phase: NA
-
FLARE Lupus Research Study Systemic Lupus Erythematosus
NCT03426384 ·Status: COMPLETED ·Phase: NA
-
Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients
NCT05478018 ·Status: COMPLETED ·Phase: NA
-
QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE)
NCT01031797 ·Status: COMPLETED
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Validation of Patient E-tool to Measure Systemic Lupus Activity
NCT05763225 ·Status: COMPLETED
-
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
NCT02319525 ·Status: COMPLETED ·Phase: NA
-
REACH (Restore Energy, Activity Can Help) Lupus Study
NCT06479213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
NCT03953690 ·Status: TERMINATED